Viewing StudyNCT00141453



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00141453
Status: COMPLETED
Last Update Posted: 2011-05-10
First Post: 2005-08-31

Brief Title: ORIENT Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
Sponsor: Daiichi Sankyo Co Ltd
Organization: Daiichi Sankyo

Conditions & Keywords Data

Conditions:
Name
Proteinuria
Diabetic Nephropathy
Type 2 Diabetes Mellitus
Keywords:
Name View
olmesartan medoxomil View
angiotensin II type I receptor blockers View
diabetic nephropathy View
end-stage renal disease View
renal failure View
type 2 diabetes View